Parrish Capital
GILD icon

Parrish Capital’s Gilead Sciences GILD Stock Holding History

Parrish Capital’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.75M Sell
18,434
-1,106
-6% -$155K 2.68% 5
2026
Q2 		$2.47M Sell
19,540
-3,206
-14% -$422K 2.38% 7
2026
Q1 		$3.17M Sell
22,746
-1,149
-5% -$161K 2.83% 3
2025
Q4 		$2.93M Buy
+23,895
New +$2.9M 2.66% 5

Other funds holding GILD

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
ProShare Advisors
ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $57B AUM 43.56% 1-Year Est. Return
Bank Julius Baer & Co
Bank Julius Baer & Co Zurich, Switzerland $39.3B AUM 31.81% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Parrish Capital's GILD Position: Q3 2026 in Review

Parrish Capital reduced its Gilead Sciences (GILD) stake by 5.7% in Q3 2026, selling an estimated $155K and leaving 18,434 shares worth $2.75M. The position accounts for 2.68% of the portfolio, ranked #5.

Parrish Capital first reported a position in GILD in Q4 2025 and has held it in 4 quarters since. The position peaked at $3.17M in Q1 2026. 976 funds tracked by Wall St. Rank hold GILD as of Q3 2026.

  • Parrish Capital held 18,434 shares of Gilead Sciences worth $2.75M as of Q3 2026.
  • Parrish Capital sold 1,106 Gilead Sciences shares in Q3 2026, an estimated $155K.
  • Gilead Sciences made up 2.68% of Parrish Capital's portfolio in Q3 2026, its #5 holding.
  • Parrish Capital first reported a position in Gilead Sciences in Q4 2025 and has held it in 4 quarters since.
  • Parrish Capital's Gilead Sciences position peaked at $3.17M in Q1 2026.
  • 976 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.

Based on Parrish Capital's 13F filing for Q3 2026, filed 1 Oct 2026.